Parameterization of the Durations of Phases of Foot-And-Mouth Disease in Cattle.
FMD
FMDV
cattle
epidemiology
foot-and-mouth disease
modeling
parameterization
virus
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2019
2019
Historique:
received:
12
12
2018
accepted:
26
07
2019
entrez:
27
8
2019
pubmed:
27
8
2019
medline:
27
8
2019
Statut:
epublish
Résumé
The objective of the current study was to update parameterization of mathematical simulation models for foot-and-mouth disease (FMD) spread in cattle utilizing recent knowledge of FMD virus (FMDV) pathogenesis and infection dynamics to estimate the duration of distinct phases of FMD. Specifically, the durations of incubation, latent, and infectious periods were estimated for 3 serotypes (O, Asia1, and A) of FMDV, individually and collectively (pan-serotypic). Animal-level data were used in Accelerated Failure Time (AFT) models to estimate the duration of the defined phases of infection, while also investigating the influence of factors related to the experimental design (exposure methods) and virus serotype on disease progression. Substantial influences upon the estimated duration of distinct phases of FMD included the quantity of viral shedding used as a proxy for the onset of infectiousness, virus serotypes, and experimental exposure methods. The use of detection of any viral RNA in nasal secretions as a proxy of infectiousness lengthened the total infectious period compared to use of threshold-based detection. Additionally, the experimental system used to infect the animals also had significant effects on the duration of distinct phases of disease. Overall, the mean [95% Confidence Interval (CI)] durations of pan-serotype disease phases in cattle were estimated to be: incubation phase = 3.6 days (2.7-4.8), latent phase = 1.5 days (1.1-2.1), subclinical infectious phase = 2.2 days (1.5-3.5), clinical infectious phase = 8.5 days (6.2-11.6), and total infectious phase = 10.8 days (8.2-14.2). This study highlights the importance of identifying appropriate proxy measures to define the onset and duration of infectiousness in FMDV-infected cattle in the absence of actual transmission data. Additionally, it is demonstrated herein that factors associated with experimental design, such as virus exposure methods, may significantly affect disease progression in individual animals and should be considered when data is extrapolated from experimental studies. Given limitations in experimental data availability, pan-serotypic parameters which include all routes of exposure and a threshold-defined onset of infectiousness may be the most robust parameters for exploratory disease spread modeling approaches, when information on the specific virus of interest is not available.
Identifiants
pubmed: 31448297
doi: 10.3389/fvets.2019.00263
pmc: PMC6696987
doi:
Types de publication
Journal Article
Langues
eng
Pagination
263Références
Epidemiol Infect. 2002 Apr;128(2):325-32
pubmed: 12002551
J Am Vet Med Assoc. 2002 Apr 1;220(7):988-92
pubmed: 12420775
Rev Sci Tech. 2002 Dec;21(3):499-504
pubmed: 12523690
Rev Sci Tech. 2002 Dec;21(3):699-710
pubmed: 12523708
J Comp Pathol. 2003 Nov;129(4):268-82
pubmed: 14554125
Clin Microbiol Rev. 2004 Apr;17(2):465-93
pubmed: 15084510
Expert Rev Anti Infect Ther. 2003 Dec;1(4):579-86
pubmed: 15482155
Prev Vet Med. 2007 Jun 15;80(1):9-23
pubmed: 17316848
Vet J. 2008 Aug;177(2):159-68
pubmed: 17509917
Risk Anal. 2008 Apr;28(2):303-9
pubmed: 18419650
Prev Vet Med. 2009 Feb 1;88(2):158-63
pubmed: 18929417
Vet Res. 2010 Jul-Aug;41(4):45
pubmed: 20205988
Vet Pathol. 2010 Nov;47(6):1048-63
pubmed: 20587691
Science. 2011 May 6;332(6030):726-9
pubmed: 21551063
Transbound Emerg Dis. 2011 Aug;58(4):305-26
pubmed: 21672184
Rev Sci Tech. 2011 Aug;30(2):483-98
pubmed: 21961220
Vet Microbiol. 2013 Sep 27;166(1-2):84-90
pubmed: 23830685
Virology. 2013 Nov;446(1-2):260-7
pubmed: 24074589
Prev Vet Med. 2014 Jan 1;113(1):23-33
pubmed: 24182985
J Am Vet Med Assoc. 2014 Feb 1;244(3):291-8
pubmed: 24432961
Res Vet Sci. 2014 Apr;96(2):396-405
pubmed: 24548596
Transbound Emerg Dis. 2016 Feb;63(1):e27-38
pubmed: 24735162
Arch Virol. 2014 Nov;159(11):2901-8
pubmed: 24938483
Transbound Emerg Dis. 2017 Apr;64(2):316-332
pubmed: 25996568
PLoS One. 2015 Jun 25;10(6):e0128815
pubmed: 26110772
PLoS One. 2015 Jun 26;10(6):e0129134
pubmed: 26114546
PLoS One. 2015 Nov 23;10(11):e0143666
pubmed: 26599543
PLoS One. 2016 Jan 06;11(1):e0146445
pubmed: 26735130
J Virol. 2016 Jun 24;90(14):6344-64
pubmed: 27147736
J Comp Pathol. 2016 Nov;155(4):314-325
pubmed: 27697284
Front Vet Sci. 2016 Nov 21;3:105
pubmed: 27917386
Sci Rep. 2017 Dec 1;7(1):16774
pubmed: 29196741
Transbound Emerg Dis. 2018 Dec;65(6):1836-1850
pubmed: 30035376
Front Vet Sci. 2018 Jul 20;5:167
pubmed: 30079340
Front Vet Sci. 2018 Jul 27;5:174
pubmed: 30101147
Proc Annu Meet U S Anim Health Assoc. 1974;(78):169-80
pubmed: 4534754
Epidemiol Infect. 1997 Apr;118(2):181-7
pubmed: 9129595